The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.
Malassezia folliculitis is a common disease of young and middle-aged people. It is an inflammatory disease caused by Malassezia infection. Generally, Topical or systemic use of antifungal drugs are the first choice for treatment but sometimes are limited due to adverse drug reactions and drug resistance. Cold atmospheric plasma has an inhibitory or killing effect on pathogenic microorganisms including fungi and has no obvious adverse damage to normal tissues. The investigators conduct this randomized controlled trial to study the effect of cold atmospheric plasma on Malassezia folliculitis, and evaluate its effectiveness and safety for Malassezia folliculitis. All data are recorded and compared after the end of the experiment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
50
Treat with cold atmospheric plasma treatment device.
Treat with Itraconazole capsules
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
50% reduction in number of lesion
proportion of subjects who achieve at least a 50% reduction in total number of lesions
Time frame: week 2
proportion of subjects in physician's global assessment.
proportion of subjects who achieve a physician's global assessment 0 / 1.
Time frame: week 2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.